#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Macular telangiectasia Krabbe's disease Chronic lymphocytic leukaemia recurrent Hypereosinophilic syndrome Nephrotic syndrome Renal cancer metastatic Thromboangiitis obliterans Infantile spasms Short-bowel syndrome Bladder cancer Non-small cell lung cancer Intracranial germ cell tumour Still's disease Basal cell naevus syndrome Neurodevelopmental disorder More trials…

    Learn about Rare Diseases

    Behcet’s syndrome – Basic Information KBG syndrome – Diagnostics Propionic acidaemia – Diagnostics Angiosarcoma metastatic – Trials in Disease Andersen-Tawil syndrome – Diagnostics Mucopolysaccharidosis II Haemophilia A without inhibitors – Treatment Andersen-Tawil syndrome Myxofibrosarcoma – Life with Disease Medulloblastoma recurrent – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    WEF-001 Xxb750 Pazopanib Carvedilol Axitinib Voriconazole Difelikefalin Crd-4730 Daratumumab Enfortumab Vedotin Cagrilintide Azd5004 Sildenafil Sarilumab Tucatinib Morf-057 Omp10 Ergocalciferol Glutenin Water For Injections More therapies…

    Learn about Your Condition

    Corneal graft rejection Hepatotoxicity Primary hypogonadism Thrombolysis Migraine with aura Tendon injury Medulloblastoma recurrent Meniscus injury Fibrosarcoma metastatic Viral myocarditis Chondrocalcinosis Thyroid disorder Contusion Oesophageal cancer metastatic Acute promyelocytic leukaemia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Azienda Ospedaliera Ospedali Riuniti Villa Sofia Cervello…

Azienda Ospedaliera Ospedali Riuniti Villa Sofia Cervello

Via Trabucco 180, Palermo, 90146, Italy

Want to learn more about this study or check if you can participate? Contact us.

  • Study on Bendamustine, Rituximab, and Acalabrutinib for Patients with Untreated Mantle Cell Lymphoma

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Acalabrutinib
    • Bendamustine Hydrochloride
    • Rituximab
    Belgium Czechia France Germany Greece Hungary +3
  • Study on the Effectiveness and Safety of Pirtobrutinib vs. Ibrutinib for Patients with Previously Treated Mantle Cell Lymphoma

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Mantle cell lymphoma
    Investigated Drugs:
    • Ibrutinib
    • Pirtobrutinib
    Austria Belgium Czechia Denmark France Germany +5
  • Study Comparing Talquetamab, Daratumumab, and Pomalidomide with Drug Combination for Patients with Relapsed or Refractory Multiple Myeloma

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Daratumumab
    • Dexamethasone
    • Dexamethasone Ph. Eur.
    Belgium Czechia France Germany Greece Italy +3
  • Study of venetoclax and azacitidine treatment in adults with NPM1-mutated acute myeloid leukemia who experience molecular relapse or disease progression

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Azacitidine
    • Venetoclax
    Italy
  • Study on Golcadomide and R-CHOP Drug Combination for Patients with Untreated High-risk Large B-cell Lymphoma

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Golcadomide
    • Apixaban
    • Betamethasone Sodium Phosphate
    Austria Bulgaria Czechia Denmark Finland France +11
  • Study on Deucrictibant and Icatibant for Treating Hereditary Angioedema Attacks in Adolescents and Adults

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Deucrictibant
    • Icatibant
    Austria Bulgaria Czechia France Germany Hungary +8
  • Study on Asundexian for Preventing Ischemic Stroke in Adults After a Stroke or High-Risk Mini-Stroke

    Not recruiting

    3 1
    Investigated Drugs:
    • Asundexian
    Austria Belgium Bulgaria Czechia Denmark Finland +14
  • Study on the Safety and Effectiveness of Dupilumab for Adults and Adolescents with Eosinophilic Gastritis and Eosinophilic Duodenitis

    Not recruiting

    2 1 1
    Investigated Drugs:
    • Dupilumab
    France Italy Poland
  • Study to Test BI 765845 for Patients with Heart Attack

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Acute myocardial infarction
    Investigated Drugs:
    • Bi 765845
    • Gadobutrol
    Czechia Germany Hungary Italy Poland Slovakia +1
  • Study on Long-Term Safety and Effectiveness of Upadacitinib for Patients with Ulcerative Colitis

    Not recruiting

    3 1
    Investigated Diseases:
    • Colitis ulcerative
    Investigated Drugs:
    • Upadacitinib
    Austria Belgium Croatia Czechia Estonia Finland +14
Previous Page
1 … 7 8 9 10 11
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!